Rail-Splitter Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-66,896
Closed -$6.14M 46
2016
Q1
$6.14M Sell
66,896
-48,915
-42% -$4.41M 1.53% 33
2015
Q4
$11.7M Buy
115,811
+10,355
+10% +$1.08M 2.77% 14
2015
Q3
$10.4M Buy
105,456
+29,015
+38% +$3.22M 2.86% 17
2015
Q2
$8.95M Buy
76,441
+9,497
+14% +$1.04M 2.58% 16
2015
Q1
$6.57M Buy
66,944
+24,346
+57% +$2.47M 2.01% 31
2014
Q4
$4.01M Sell
42,598
-38,405
-47% -$3.97M 1.23% 32
2014
Q3
$8.62M Buy
+81,003
New +$7.93M 2.83% 20
2014
Q2
Sell
-111,000
Closed -$7.87M 41
2014
Q1
$7.87M Sell
111,000
-12,710
-10% -$997K 2.6% 19
2013
Q4
$9.29M Buy
123,710
+35,210
+40% +$2.45M 3.21% 7
2013
Q3
$5.56M Sell
88,500
-17,900
-17% -$1.07M 2.37% 23
2013
Q2
$5.46M Buy
+106,400
New +$5.55M 2.41% 18

Other funds holding GILD

Rail-Splitter Capital Management's GILD Position: Q2 2016 in Review

Rail-Splitter Capital Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 66,896 shares — an estimated $6.14M sold.

Rail-Splitter Capital Management first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $11.7M in Q4 2015. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Rail-Splitter Capital Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Rail-Splitter Capital Management sold 66,896 Gilead Sciences shares in Q2 2016, an estimated $6.14M.
  • Rail-Splitter Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
  • Rail-Splitter Capital Management's Gilead Sciences position peaked at $11.7M in Q4 2015.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Rail-Splitter Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.